Predictive value of FDG-PET imaging for relapse in metastatic melanoma patients treated with immunotherapy.
Anti-PD1 immunotherapy has shown a sustainable clinical activity in patients with metastatic melanoma. However, strong predictive factors of the long-term response or risk of relapse remain to be identified.
- Ref: doi: 10.1111/jdv.16358
- Année de publication : 2020
- Auteurs : Mesnard C, Bodet-Milin C, Eugène T, Nguyen JM, Khammari A, Dréno B.
- Réseaux : Réseaux: « Immunothérapies »